![Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease](https://www.frontiersin.org/files/Articles/769506/fnagi-13-769506-HTML/image_m/fnagi-13-769506-g001.jpg)
Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease
![How is alpha‐synuclein cleared from the cell? - Stefanis - 2019 - Journal of Neurochemistry - Wiley Online Library How is alpha‐synuclein cleared from the cell? - Stefanis - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/10f1c59e-8c82-47e5-a448-92f76dddf56b/jnc14704-fig-0003-m.png)
How is alpha‐synuclein cleared from the cell? - Stefanis - 2019 - Journal of Neurochemistry - Wiley Online Library
![Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications](https://www.degruyter.com/document/doi/10.1515/hsz-2016-0201/asset/graphic/j_hsz-2016-0201_fig_001.jpg)
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
![3D structures of tau and alpha-synuclein proteins vary by brain disease, several studies show | National Institute on Aging 3D structures of tau and alpha-synuclein proteins vary by brain disease, several studies show | National Institute on Aging](https://www.nia.nih.gov/sites/default/files/inline-images/alpha-synuclein-3Dstructure.jpg)
3D structures of tau and alpha-synuclein proteins vary by brain disease, several studies show | National Institute on Aging
![α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro](https://www.eneuro.org/content/eneuro/8/1/ENEURO.0330-20.2020/F1.large.jpg)
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro
![Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bc8af0e3-82f3-4fcc-86c2-66b5ce842dcb/jnc14806-fig-0002-m.jpg)
Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library
![Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease](https://www.frontiersin.org/files/Articles/520527/fnagi-12-00072-HTML/image_m/fnagi-12-00072-g001.jpg)
Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease
![IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease](https://www.mdpi.com/ijms/ijms-21-08666/article_deploy/html/images/ijms-21-08666-g001.png)